LGALS3 and neoplasm: However, it was unclear whether this in vivo effect was galectin-3-dependent, and if so, whether the therapeutic effect resulted from the interaction of the peptide with human galectin-3 or mouse galectin-3 secreted by the host in the tumor microenvironment.